Boehringer Reports First Phase III Results For Survodutide In Obesity – But Is It Enough?

Five More Pivotal Trials To Read Out In 2026

 
• By Mandy Jackson
  
Overweight Patient Measuring Waist
Reduction in waist circumference was a key secondary endpoint (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Trial Results

More from R&D